AbbVie Inc. (ABBV) vs Microsoft Corporation (MSFT)

See how AbbVie Inc. and Microsoft Corporation differ across market data and performance, so you can decide which asset best fits your strategy.

$256.42
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page
$507.29
NasdaqGS
Microsoft Corp develops and licenses software for both consumer and enterprise markets. The company is best known for its Windows operating systems and Office productivity applications. Its business is organized into three broadly equal segments: Productivity and Business Processes, which includes legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, and Dynamics; Intelligent Cloud, which includes Azure infrastructure- and platform-as-a-service offerings, Windows Server, and SQL Server; and More Personal Computing, which includes Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktop devices.
View Full Page

Key Metrics Comparison

AbbVie Inc.ABBV
Market Cap
$453.124B
Price
$256.42
24h Change
+0.37%
24h Volume
$4.24M
Employees
57,000
Shares Outstanding
1,768,169,012
Microsoft CorporationMSFT
Market Cap
$3.767T
Price
$507.29
24h Change
-1.22%
24h Volume
$26.64M
Employees
228,000
Shares Outstanding
7,428,434,704

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
ABBV
10.7%
MSFT
89.3%

Volume Share

Share of combined 24h volume

Volume Share
ABBV
13.7%
MSFT
86.3%

24h Performance

Price change over last 24 hours

24h Performance
ABBV
0.37%
MSFT
-1.22%
Price Comparison
AbbVie Inc.
Microsoft Corporation